newsfilter
← Latest News
FDA Approved Drugs·

Approval of Gomekli, Nda #219379 (Type 1 - New Molecular Entity)

Approval Date: 02/11/2025; Drug Name: Gomekli, Nda #219379; Active Ingredients: MIRDAMETINIB; Company: Springworks Therapeutics Inc; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity; Application Number: 219379

Company
SPRINGWORKS THERAPEUTICS INC
Keywords
SPRINGWORKS THERAPEUTICS INC